2020
June 05, 2020 - BioMarker Strategies today announced the promotion of Greg Bertenshaw. Ph.D., to the position of Chief Operating and Science Officer. Press Release
June 05, 2020 - BioMarker Strategies to Present at BIO Digital Next Week. Press Release
January 07, 2020 - BioMarker Strategies Awarded Phase II National Cancer Institute Contract to Develop Novel Predictive Test for Response to Immunotherapies for Patients with Non-Small Cell Lung Cancer. Press Release
January 06, 2020 - BioMarker Strategies to Present at Biotech Showcase 2020 in San Francisco During J.P. Morgan Healthcare Conference Week. Press Release
2019
June 03, 2019 - BioMarker Strategies Announces that Both of Its Core Diagnostics Technologies for Solid Tumor Cancers Are Now Covered by Patents Granted in Korea. Press Release
June 02, 2019 - BioMarker Strategies to Present at the BIO 2019 International Convention in Philadelphia. Press Release
2018
June 04, 2018 - BioMarker Strategies Announces Chinese Patent for PathMAP Functional Signaling Profile Technology. Press Release
March 28, 2018 - BioMarker Strategies Announces that Both of Its Core Diagnostics Technologies for Solid Tumor Cancers Are Now Covered by New Patents Granted in Canada. Press Release
2017
October 3, 2017 - BioMarker Strategies Announces Phase I National Cancer Institute Grant to Develop Companion Diagnostic to Identify Patients with Head and Neck Cancer Who Are Most Likely to Respond to Treatment with Cetuximab. Press Release
September 25, 2017 - BioMarker Strategies Announces United States Patent for PathMAP Functional Signaling Profile Technology. Press Release
September 11, 2017 - BioMarker Strategies Announces Phase II National Cancer Institute Grant to Continue Development of Companion Diagnostic Test to Help Select Optimal Therapy for Patients with Non-Small Cell Lung Cancer. Press Release
August 31, 2017 - BioMarker Strategies Announces Two New Patents Granted in Japan, Covering the Company’s Core Diagnostics Technologies for Solid Tumor Cancers. Press Release
July 19, 2017 - BioMarker Strategies Announces Issuance of Key Patent in Europe Covering the Company’s PathMAP® Functional Signaling Profile Technology. Press Release
2016
September 19, 2016 - BioMarker Strategies Awarded Phase I National Cancer Institute Contract to Develop Novel Predictive Test for Response to Immunotherapies for Patients with Non-Small Cell Lung Cancer. Press Release
June 29, 2016 - BioMarker Strategies Awarded Phase I/II Fast Track National Cancer Institute Grant to Develop Companion Diagnostic Test to Select Optimal Therapy for Patients with Non-Small Cell Lung Cancer. Press Release
January 7, 2016 - BioMarker Strategies Announces Issuance of Key Patents in the United States, Europe, Australia and Hong Kong. Press Release
2015
August 31, 2015 - StockNewsNow.com Publishes New SNNLive Video Interview With BioMarker Strategies, LLC. Press Release
2014
March 24, 2014 - MD+DI Highlight the SnapPath® Testing System as 1 of 6 Promising IVD Technologies that Will Change Cancer Testing. Press Release
February 11, 2014 - Bioradiations Describe Profiling Dynamic Cancer Drug Responses with the SnapPath® Testing System and the Bio-Plex® Multiplex Immunoassay System. Press Release
January 13, 2014 - Frost & Sullivan Recognizes BioMarker Strategies for its Ground-Breaking Innovation in Solid Tumor Diagnostics. Press Release
2013
October 1, 2013 - BioMarker Strategies Names Jerry Parrott President, Chief Executive Officer and Director. Press Release
September 25, 2013 - BioMarker Strategies Awarded $1.5 Million National Cancer Institute Contract to Develop Companion Diagnostic Test to Select Optimal Therapy for Melanoma Patients. Press Release
April 9, 2013 - BioMarker Strategies and Champions Oncology announce results of scientific collaboration at the AACR Annual Meeting in Washington, DC.
Press Release
2012
December 28, 2012 - Jointly, with collaborators from The University of Pennsylvania and The Wistar Institute, BioMarker Strategies publishes a paper, entitled "Functional Profiling of Live Melanoma Samples Using a Novel Automated Platform," in the peer-reviewed PLoS ONE journal. Read Paper
October 3, 2012 - BioMarker Strategies names Jack Davis as Executive Chairman and senior strategic management advisor to the company. Most recently, Mr. Davis served as a co-founder, President/COO and later CEO and Chairman of Dianon Systems, Inc. Press Release
August 29, 2012 - Listen to Scott Allocco, co-founder and director of BioMarker Strategies, speak about the company's live tumor cell testing in an interview with SNNLive. Interview
May 22, 2012 - BioMarker Strategies has been named finalist in TEDCO's Innovation, Corporate Excellence and Entrepreneurship (ICE) awards. The awards, which will be presented May 31st in Columbia, MD, recognize businesses in each of the three categories for their excellence. Read Article
May 1, 2012 - BioMarker Strategies partners with Sparton Medical Systems and HS Design to develop its novel live cell tumor testing system which was recently named a finalist in the 2012 Medical Design Excellence Awards (MDEA). Press Release
April 3, 2012 - BioMarker Strategies presented an abstract, titled Translational research platform (SnapPath®) for enabling drug development and personalized medicine in metastatic melanoma, at the 2012 AACR Annual Meeting, in Chicago, IL. Read Abstract
April 2, 2012 - The SnapPath® system was named a Finalist in the In vitro category of the 2012 Medical Design Excellence Awards (MDEA). Winners will be announced May 23rd, 2012. Press Release
March 15, 2012 - BioMarker Strategies' novel SnapPath® live-tumor-cell processing platform featured in Biomarker Analysis Making Strides, in the March issue of GEN Read Article
February 20, 2012 - Dr. Adam Schayowitz presents, "Enabling Next-Generation, Predictive Diagnostics with the SnapPath® Live Tumor Testing System," at the Early Stage Molecular Diagnostics Partnering Forum, held in conjunction with the Molecular Med Tri-Con 2012 conference in San Francisco, CA. Read Summary
Please send media inquiries to  or call 410-522-1008. |
